Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 17 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Kandaraki, Eleni A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Spanos, N., Tziomalos K., Macut D., Koiou E., Kandaraki E. A., Delkos D., et al. (2012).  Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.. Obes Facts. 5(4), 495-504.
Panidis, D., Tziomalos K., Macut D., Kandaraki E. A., Tsourdi E. A., Papadakis E., et al. (2013).  Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.. Gynecol Endocrinol. 29(10), 926-30.
Panidis, D., Tziomalos K., Chatzis P., Papadakis E., Delkos D., Tsourdi E. A., et al. (2013).  Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.. Eur J Endocrinol. 168(2), 145-52.
C
Koiou, E., Tziomalos K., Katsikis I., Kalaitzakis E., Kandaraki E. A., Tsourdi E. A., et al. (2011).  Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels.. Eur J Endocrinol. 165(1), 63-8.
Panidis, D., Tziomalos K., Papadakis E., Chatzis P., Kandaraki E. A., Tsourdi E. A., et al. (2013).  The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.. Eur J Endocrinol. 168(6), 871-7.
Tziomalos, K., Katsikis I., Papadakis E., Kandaraki E. A., Macut D., & Panidis D. (2013).  Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.. Hum Reprod. 28(3), 785-93.
E
Koiou, E., Tziomalos K., Dinas K., Katsikis I., Kalaitzakis E., Delkos D., et al. (2011).  The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome.. Endocr J. 58(4), 237-46.
Panidis, D., Tziomalos K., Koiou E., Kandaraki E. A., Tsourdi E., Delkos D., et al. (2010).  The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study.. Reprod Biol Endocrinol. 8, 151.
G
Panidis, D., Tziomalos K., Papadakis E., Kandaraki E. A., & Katsikis I. (2013).  The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require r. Hormones (Athens). 12(2), 192-200.
P
Koiou, E., Dinas K., Tziomalos K., Toulis K., Kandaraki E. A., Kalaitzakis E., et al. (2011).  The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteria.. Obes Facts. 4(2), 145-50.
Katsikis, I., Karkanaki A., Misichronis G., Delkos D., Kandaraki E. A., & Panidis D. (2011).  Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.. Eur J Obstet Gynecol Reprod Biol. 156(2), 181-5.
Koiou, E., Tziomalos K., Dinas K., Katsikis I., Kandaraki E. A., Tsourdi E., et al. (2012).  Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.. Endocr J. 59(1), 21-9.
Koiou, E., Tziomalos K., Katsikis I., Dinas K., Tsourdi E. A., Kandaraki E. A., et al. (2012).  Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome.. Hormones (Athens). 11(1), 77-85.
Koiou, E., Tziomalos K., Katsikis I., Papadakis E., Kandaraki E. A., & Panidis D. (2013).  Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome.. Gynecol Endocrinol. 29(3), 250-3.
Panidis, D., Macut D., Tziomalos K., Papadakis E., Mikhailidis K., Kandaraki E. A., et al. (2013).  Prevalence of metabolic syndrome in women with polycystic ovary syndrome.. Clin Endocrinol (Oxf). 78(4), 586-92.
R
Panidis, D., Tziomalos K., Papadakis E., Chatzis P., Kandaraki E. A., Tsourdi E. A., et al. (2014).  The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.. Clin Endocrinol (Oxf). 80(3), 432-8.
W
Koiou, E., Tziomalos K., Katsikis I., Kandaraki E. A., Kalaitzakis E., Delkos D., et al. (2012).  Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.. Gynecol Endocrinol. 28(1), 20-4.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές